Traits of patients who screen positive for dementia and refuse diagnostic assessment  by Fowler, Nicole R. et al.
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (2015) 236-241Traits of patients who screen positive for dementia and refuse diagnostic
assessmentNicole R. Fowlera,b,c,*, Amie Framea,b, Anthony J. Perkinsa,b, Sujuan Gaod, Dennis P. Watsone,
Patrick Monahand, Malaz A. Boustania,b,c
aIndiana University Center for Aging Research, Indianapolis, IN, USA
bRegenstrief Institute, Inc., Indianapolis, IN, USA
cDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
dDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA
eDepartment of Health Policy and Management, Indiana University Richard M. Fairbanks, School of Public Health, Indianapolis, IN, USAAbstract Background: As part of the debate about screening for dementia, it is critical to understand why pa-*Corresponding a
9307.
E-mail address: nf
http://dx.doi.org/10.10
2352-8729/ 2015 T
license (http://creativetients agree or disagree to diagnostic assessment after a positive screening test. We used the Percep-
tions Regarding Investigational Screening forMemory in Primary Care (PRISM-PC) questionnaire to
measure the characteristics of patients who screened positive for dementia but refused further diag-
nostic assessment.
Methods: Survey of patients 65 years old without a diagnosis of dementia attending primary care
clinics in Indianapolis, IN, in 2008 and 2009.
Results: Five hundred and fifty-four individuals completed the PRISM-PC and 63 screened positive.
Of those, 21 (33%) accepted and 42 (67%) refused diagnostic assessment. In adjusted models, having
larger stigma domain scores and living alone were significantly associated with increased odds of
refusing the diagnostic assessment.
Conclusion: Despite screening positive, many patients refused a diagnostic assessment. Living alone
and the perceived stigmas of dementia are associated with the refusal of diagnostic assessment for
dementia.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Keywords: Dementia screening; Alzheimer’s disease; Primary care; Diagnostic assessment1. Introduction
Dementia poses a major challenge to public health and
can have devastating emotional and economic impacts on
patients and their families. It is currently estimated that 5.3
million Americans have dementia and that as many as
50% of patients with dementia are never diagnosed [1–3].
Among patients aged 70 years and more with cognitive
problems, only 45% have a history of a cognitive
evaluation [4], suggesting that as many as 1.8 million Amer-uthor. Tel.: 11-317-274-9021; Fax: 11-317-274-
owler@iupui.edu
16/j.dadm.2015.01.002
he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).icans with dementia have not seen a physician about their
cognitive problems.
The driving forces for the under detection of dementia are
unclear. Patients may delay or decline a diagnostic assess-
ment for dementia because of concerns that others might
learn about their cognitive status, the belief that dementia
cannot be treated, or a general negative attitude toward med-
ical assessment [5,6]. Patient caregivers also influence the
decision to obtain a cognitive evaluation. Previous work
has found that despite caregivers acknowledging the
benefits of a cognitive evaluation, 70.3% had a hard time
accepting their family member’s cognitive decline, and
67.7% were concerned with how a diagnosis of dementia
would impact their own lives [5].imer’s Association. This is an open access article under the CC BY-NC-ND
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in performing cognitive evaluations may also contribute to
the under detection of dementia [5]. Primary care physicians
(PCPs) sometimes question the clinical usefulness of an
early diagnosis because of limited treatment options and
the need to prioritize other “treatable” health problems [7].
Those in favor of the earlier identification of dementia
argue that population-based screening will increase the like-
lihood that dementia will be diagnosed [5]. It is also argued
that early diagnosis has a variety of potential benefits
including the following: earlier evaluation and treatment of
reversible causes of cognitive symptoms [5]; improvements
in care processes and long-term outcomes by providing op-
portunities for physicians to discuss prognosis, learn about
patient’s goals, and tailor prevention and disease-
management targets [6,8,9]; and improvements in patient
and family outcomes such as knowledge about dementia,
preparedness for future medical decisions, and confidence
in medical decision making [10]. Despite these potential
benefits, it is unclear if routine screening for dementia in pri-
mary care would increase the likelihood that patients would
receive a diagnostic assessment or result in improvements in
patient and caregiver outcomes. There is no evidence that
screening for dementia delays or alters disease progression
[11,12], and relatively few studies have evaluated patient,
caregiver, and physician perceptions about the value of
early identification of dementia as a result of screening in
primary care [13–17].
In an effort to design patient-centered interventions that
will improve earlier recognition, diagnoses and patient out-
comes, it is important to understand and enumerate the rela-
tionship between attitudes and behaviors of older primary
care patients regarding dementia screening and diagnosis.
Almost half (47.7%) of primary care patients in one recent
study refused a cognitive evaluation after a positive
screening test for dementia [18]. Patients who self-
identified as African American, were 70 to 79 years old,
and who do not perceive themselves as having any decline
in their cognitive abilities were most likely to refuse diag-
nostic assessment; however, this study did not investigate
the effect of patients’ perceptions regarding dementia and
screening on their willingness to undergo diagnostic assess-
ment.
The purpose of this study is to measure older primary care
patients’ perceptions of dementia screening and compare
those perceptions between those who screened positive for
dementia and accepted a diagnostic assessment versus those
who screened positive and refused a diagnostic assessment.
Based on our previous work investigating older adults’ per-
ceptions and beliefs about screening, we hypothesized that
patients in the mid-range of our sample, ages 70 to 80 years,
would be more likely to refuse diagnostic assessment. In
addition, patients who acknowledged the benefits of early
detection of dementia would be more likely to accept a
follow-up cognitive evaluation after a positive screening
test [6,14].2. Methods
2.1. Study population
Patients were eligible to participate in our study if they
were 65 years or older, did not have a documented diagnosis
of dementia, and received their primary care at Eskenazi
Health in Indianapolis, IN. Eskenazi Health is an urban
health care system with 11 community-based primary care
practice centers staffed by faculty and residents of Indiana
University School of Medicine. In 2007, approximately
11,000 patients 65 years and older received care at Eskenazi
Health, with most of these patients visiting a PCP an average
of four times a year.
All study recruitment was conducted through the Indiana
University Practice Based Research Network (IU-PBRN).
The IU-PBRN is a research network that uses informatics
tools to coordinate the recruitment of primary care patients
into local research studies. The IU-PBRN research assis-
tants, who are trained in the protection of patient privacy
and institutional review board (IRB) policies and procedures
for conducting research with human subjects, approached
eligible patients within the primary care clinics and obtained
informed consent from thosewho agreed to participate in the
study. This study was approved by the Indiana University,
Purdue University-Indianapolis’s IRB.2.2. Study procedures and instruments
Patients’ perceptions about dementia and screening for de-
mentia were obtained through face-to-face encounters and
measured with the Perceptions Regarding Investigational
Screening for Memory in Primary Care (PRISM-PC) ques-
tionnaire. The PRISM-PC questionnaire consists of 50 items,
including 12 items on the sociodemographic characteristics of
the participants and their experiences with Alzheimer’s dis-
ease. The remaining 38 items measure patients’ experiences
with dementia, their perceptions of the benefits and harms
of screening for dementia, and their perceptions regarding
the acceptability of dementia screening with different
methods. These 38 items are scored on a 5-point Likert scale
(“strongly agree” to “strongly disagree”) (Supplementary
Material). The psychometric properties of the PRISM-PC
questionnaire have been previously published [13].
At the time of enrollment, patients were asked to com-
plete the PRISM-PC questionnaire first and then asked if
they would be willing to be screened for memory problems
using one of two paper-and-pencil screening instruments:
(1) Community Screening Instrument for Dementia (CSI-
D) [19] or (2) Mini-Mental State Examination (MMSE)
[20]. If they agreed, the research assistant would administer
the cognitive screen and follow a script based on the patient’s
score. Two screening instruments were used because of a
change in protocol from a concurrent study that was
enrolling patients from the same clinics.
For patients who screened 24 on MMSE and CSI-D,
they were reassured that the screening test was not a
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by the Healthy Aging Brain Center (HABC) at Eskenazi
Health for a complete cognitive evaluation and diagnostic
assessment. Program coordinators from the HABC attemp-
ted to contact participants who screened positive on multiple
occasions over a 6-month period after the positive screening
test. The HABC program has two phases: an initial assess-
ment phase and a follow-up phase. An individualized care
plan is developed in the first phase of the program after a
full cognitive evaluation that includes a structured neurolog-
ical and physical examination, neuropsychological testing,
blood work, brain imaging, and a diagnostic conference
with the patient and their family. The follow-up phase
focuses on monitoring and the modification of the collabora-
tive care plan based on continued interaction with the patient
and caregiver and input from the HABC team and the pa-
tient’s PCP [17]. In the study presented here, we examined
responses on the PRISM-PC questionnaire for only the pa-
tients who screened positive for dementia and we compared
responses between those who agreed and refused a cognitive
evaluation and diagnostic assessment.Table 1
Comparison of the sociodemographic characteristics of study participants
who accepted and refused diagnostic assessment for dementia
Variable
No. (%) of pts.
(accepted
diagnostic
assessment;
n 5 21)
No. (%) of pts.
(refused
diagnostic
assessment;
n 5 42) P value
Age groups (yr) .4483. Statistical analyses
Before conducting the analyses, we reverse-coded re-
sponses on the PRISM-PC questionnaire so that a higher
score indicated stronger agreement with the items. To facil-
itate the interpretation of the domain scores, we converted all
domains to the same metric by taking the sum of the reverse-
coded responses and then transformed the sum to a 0 to 100
scale by subtracting the minimum possible score and
dividing it by the possible range. For a given domain, this
meant that 0 represented “strongly disagree” on all items,
100 represented “strongly agree” on all items, and 50 repre-
sented neutral scores on all items.
We used the Fisher exact test for categorical variables and
the two-sample t test for continuous variables to compare de-
mographics and PRISM-PC domain scores across diagnostic
assessment status. To model the association of the PRISM-
PC domains and demographics with the refusal of diagnostic
assessment, we used logistic regression using the variables
with P-values ,.10 from the univariate analyses. The final
model retained only variables significant at the .05 level.
For all statistical analyses, we used SAS statistical software
version 9.3 (SAS Institute Inc., Cary, NC).65–69 4 (19.1) 15 (35.7)
70–74 7 (33.3) 8 (19.1)
75–79 6 (28.6) 10 (23.8)
80 4 (19.1) 9 (21.4)
Gender, female 14 (66.7) 25 (59.5) .784
Race, nonwhite 13 (61.9) 23 (54.8) .788
Years of education, 0–11 yrs 18 (85.7) 27 (63.3) .138
Lives alone 5 (23.8) 25 (59.5) .008
Marital status, married 7 (33.3) 8 (19.0) .227
Annual income .072
,$10,000 7 (33.3) 10 (23.8)
$10,000–$19,999 4 (19.1) 24 (57.1)
Missing 10 (47.6) 8 (19.1)4. Results
Of the 1065 patients asked to participate in this study, 554
agreed and provided informed consent. The 511 nonpartici-
pants did not vary significantly from the participants in terms
of age (P5 .07), sex (P5 .19), or race or ethnicity (P5 .62).
Among the 554 who completed the PRISM-PC question-
naire, 497 (89.7%) agreed to dementia screening and details
about this sample have been previously reported [14]. Of the
497, 63 (12.7%) patients screened positive and were referredfor the HABC for diagnostic assessment. Among the 63
referred for a full cognitive evaluation, 21 (33.3%) accepted
and completed the cognitive evaluation and diagnostic
assessment and 42 (66.7%) refused. A participant was
counted as a refusal if they reported to the HABC program
coordinator that they did not want to be evaluated or if
they were unable to be reached or scheduled for an appoint-
ment in the 6 months after the positive screening test.
Most respondents who screened positive and were
referred for diagnostic assessment were female (61.9%),
African Americans (55.6%), and had an annual income
less than $20,000 (88.9%). Approximately half of the re-
spondents were widowed, 71% had less than a high school
education, and 48% lived alone. Comparisons of diagnostic
assessment refusal rates by sociodemographic characteris-
tics are presented in Table 1. Respondents who lived alone
were significantly more likely to refuse the diagnostic
assessment than those living with someone. Respondents
with an annual income of $10,000 or more were more likely
to refuse the diagnostic assessment compared with those
with an annual income less than $10,000, although only
marginally significantly different likely because of the sam-
ple size and that 28.6% of the sample had missing income
data.
Tables 2 and 3 present comparisons of PRISM-PC do-
mains and items by diagnostic assessment. Patients who
refused diagnostic assessment had significantly higher
stigma domain scores on the PRISM-PC questionnaire
compared with those who agreed and completed the diag-
nostic assessment. Respondents who refused the diagnostic
assessment generally had higher scores on each item in the
stigma domain. No other domains were significantly
different between the two groups. Respondents who agreed
to a diagnostic assessment were significantly more likely
Table 2
Comparison of responses to questions on the PRISM-PC of study participants who accepted and refused diagnostic assessment for dementia
Items on the PRISM-PC
No. (%) who accepted
diagnostic assessment (n 5 21)
No. (%) who refused
diagnostic assessment (n 5 42) P value
Do you have a relative or friend with Alzheimer’s disease*? Yes 5 (23.8) 9 (21.4) 1.000
Do you believe that you are at a higher risk of Alzheimer’s disease than
others of your same age? Yes
3 (14.3) 8 (19.0) .738
Do you think you havemore memory problems than others of your same
age? Yes
6 (28.6) 8 (19.0) .349
Has a doctor told you that you have memory problems? Yes 1 (4.8) 1 (2.4) 1.000
Are you taking medication to help with memory? Yes 1 (4.8) 1 (2.4) 1.000
Abbreviation: PRISM-PC, Perceptions Regarding Investigational Screening for Memory in Primary Care.
*Because our early work indicated that patients more readily understood the term “Alzheimer’s disease” than the term “dementia,” we used “Alzheimer’s
disease” as a proxy for dementia for this study.
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items were marginally significant (.05 , P , .10) and
were considered for evaluation. Respondents who refused
the diagnostic assessment tended to have higher incomes
and be more likely to agree that a treatment for Alzheimer’s
disease (AD) is not currently available.
In a final adjusted logistic model for refusing diagnostic
assessment, three variables were statistically significant.
Larger stigma domain scores (adjusted odds ratio [AOR]
for 5-point increase 1.43; 95% confidence interval [CI]
1.04, 1.98) and living alone (AOR 7.28; 95% CI 1.81,
29.29) were significantly associated with increased odds of
refusing the diagnostic assessment. In addition, higher
agreement with colorectal cancer screening was associated
with the decreased odds of refusing diagnostic assessment
for dementia (AOR 0.25; 95% CI 0.07, 0.90).5. Discussion
This is the first study to examine the relationship between
older primary care patients’ attitudes about dementia
screening and their behavior regarding cognitive evaluations
following a positive dementia screening test. More than half
of the 63 (66.7%) study participants who screened positive
refused a follow-up cognitive evaluation and diagnostic
assessment. Patients’ perceptions of the stigmas surroundingTable 3
Comparison of PRISM-PC scales between participants who screened positive and
diagnostic assessment
PRISM-PC domains
Acceptance of dementia screening
Benefits of dementia screening
Stigma of dementia screening
Negative impact of dementia screening on independence
Suffering related to dementia screening
Individual questions not included in a domain score
Acceptance with colorectal cancer screening
Acceptance with depression screening
Belief that a treatment for Alzheimer’s disease is not currently available
Abbreviations: PRISM-PC, Perceptions Regarding Investigational Screening fodementia and dementia screening were associated with the
refusal of diagnostic assessment.
The findings from our study are important given the low
rates of detection of dementia and the high percentage older
adults with dementia who never receive a cognitive evalua-
tion. Early intervention and education of patients and their
caregivers on dementia and dementia screening could
increase the number of patients seeking diagnostic assess-
ment, specifically those that address the perceived stigmas
associated with dementia screening.
Living alone was the only demographic characteristic
associated with the refusal of a diagnostic assessment.
This finding is comparablewith other studies that have found
a relationship between marital status and higher rates of
cognitive evaluations and diagnoses [4]. Approximately
half of the participants eligible for a diagnostic assessment
were widowed. Although not statistically significant, pa-
tients who were not married had higher refusal rates for
the diagnostic assessment than those who were married.
This complements earlier work that has shown patients
with an identified caregiver and the caregivers themselves
overwhelmingly want information about a dementia diag-
nosis [21]. Taken together, this suggests that patients without
a potential caregiver may be less likely to agree to a cogni-
tive evaluation and diagnostic assessment and more likely to
perceive stigma associated with a diagnosis. This may beaccepted diagnostic assessment (DA) for dementia and those who refused
Accepted DA, mean
(SD) (n 5 21)
Refused DA, mean
(SD) (n 5 42) P value
67.6 (13.3) 60.9 (17.6) .128
73.5 (9.5) 70.8 (11.2) .339
35.2 (10.7) 42.0 (13.1) .045
47.7 (14.2) 51.8 (16.2) .318
50.9 (19.2) 51.3 (13.3) .921
4.0 (0.5) 3.5 (0.9) .047
3.8 (0.8) 3.5 (0.9) .361
2.5 (0.9) 2.9 (0.9) .059
r Memory in Primary Care; SD, standard deviation.
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impairments may lead to loss of activities such as driving
and the independence they have been accustomed to. For
most patients with dementia, the person living with the pa-
tient assumes the role of the caregiver [22]. In the absence
of a caregiver, the patient is challenged to find physical
and social support, which are important mediators for a va-
riety of health outcomes [23,24].
Patients who accepted a cognitive evaluation and diag-
nostic assessment were more likely to agree to the item
on the PRISM-PC regarding a desire for an examination
for colorectal cancer by their physician. This may be
because of a patient’s overall feeling that screening and
testing is a good health behavior or because of an acknowl-
edgment that both dementia and colorectal diseases are
associated with age and should be addressed as a person
gets older. Previous studies show that a general lack of
knowledge about dementia and its etiology and symptom-
atology are strong barriers to receiving a diagnosis. Inter-
estingly, our previous work has shown that patients
beliefs about cognitive decline as a normal aging process
may prevent patients from seeking a diagnosis and getting
more information [10].
Limitations to the study include a small sample size and
generalizability. Nevertheless, despite lower power from a
small sample, several relationships were statistically signif-
icant. A very small percentage of participants screened pos-
itive (12.7%) with an even smaller sample completing the
diagnostic assessment. Given the findings discussed previ-
ously, it is interesting that the relationship between patients’
perceptions of dementia screening’s effect on independence
and their decision to refuse the assessment was not signifi-
cant. This may be because of the small sample size, and
future work should further investigate the relationship
between these two variables. Although the study cohort
consisted primarily of minority and low socioeconomic indi-
viduals, inferences can be made that are useful in developing
educational programs and interventions, specifically for
older primary care patients. Another limitation was our
lack of ability to track if the patients who screened positive
and refused a cognitive evaluation and diagnostic assess-
ment sought further evaluation from their own physician
or program outside the HABC.6. Conclusion
Most patients, despite screening positive for dementia,
refused a diagnostic assessment. Patients who completed
the diagnostic assessment were less likely to believe there
are stigmas associatedwith dementia screening and diagnosis
and were less reluctant to accept other examinations and
screenings by their PCP. The only significant difference in so-
ciodemographics between the diagnostic assessment refusal
and acceptance groups was living alone. Intervening on
patients’ perceptions about dementia diagnosis, misconcep-
tions about stigmas, and providing information about benefitsof early identification could potentially increase the number
of patients seeking diagnostic assessment of dementia.
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1. Systematic review: Patients’ willingness to be
screened for dementia and willingness to follow-up
with diagnostic assessment after a positive screen
has been shown to be related to their perceptions
about their own cognitive health and about the harms
of receiving a dementia diagnosis especially in the
face of limited of treatment or preventive methods
for dementia.
2. Interpretation: Our study shows that in a sample of
community dwelling older adults who screened pos-
itive for dementia, more than half (67%), refused
diagnostic assessment after the positive screen.
Based on survey responses of those who refused a
diagnostic assessment, patients who refused diag-
nostic assessment were more likely to live alone
and agree with statements associated with stigmas
related to dementia.
3. Future directions: Intervening on patients’ percep-
tions about dementia in general, and about diagnosis
and treatment, could potentially increase the number
of patients seeking or accepting the diagnostic
assessment of dementia.References
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